Table 3.

Classification based on baseline diagnostic parameters (lipid profile and serum creatinine)—patients with coexistent triple disease

Parameter	Patient count (%)
Serum LDL–cholesterol (n = 55,114)
< 30 mg/dl	711 (1.30)
30–40 mg/dl	1628 (2.96)
40–55 mg/dl	5089 (9.24)
55–70 mg/dl	7309 (13.27)
70–100 mg/dl	15,909 (28.87)
100–130 mg/dl	12,453 (22.60)
130–160 mg/dl	7799 (14.16)
160–190 mg/dl	3035 (5.51)
≥ 190 mg/dl	1181 (2.15)
Serum total cholesterol (n = 13,918)
< 200 mg/dl	10,024 (72.03)
200–240 mg/dl	2518 (18.10)
≥ 240 mg/dl	1376 (9.89)
Serum triglycerides (n = 55,041)
< 150 mg/dl	24,035 (43.67)
150–200 mg/dl	13,205 (24)
200–500 mg/dl	17,801 (32.35)
VLDL cholesterol (n = 25,367)
≥ 30 mg/dl	10,431 (41.13)
< 30 mg/dl	14,936 (58.88)
Serum HDL–cholesterol (male) (n = 29,540)
< 40 mg/dl	13,040 (44.15)
40–60 mg/dl	15,228 (51.56)
≥ 60 mg/dl	1272 (4.31)
Serum HDL–cholesterol (female) (n = 22,906)
< 50 mg/dl	16,438 (71.77)
50–60 mg/dl	4349 (18.99)
≥ 60 mg/dl	2119 (9.26)
Serum creatinine (male) (n = 50,567)
< 0.7 mg/dl	2249 (4.45)
0.7–1.3 mg/dl	33,597 (66.45)
≥ 1.3 mg/dl	14,721 (29.12)
Serum creatinine (female) (n = 36,106)
< 0.5 mg/dl	556 (1.54)
0.5–1.1 mg/dl	26,206 (72.59)
≥ 1.1 mg/dl	9344 (25.88)

HDL high-density lipoprotein, LDL low-density lipoprotein, n number of patients, PPBS postprandial blood sugar, RBS random blood sugar, VLDL very low-density lipoprotein